國家衛生研究院 NHRI:Item 3990099045/8375
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12500/13673 (91%)
造訪人次 : 2628672      線上人數 : 334
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/8375


    題名: Use of a bayesian approach to design and evaluation of NCE2
    作者: Chang, LC;Yeh, MK;Lin, MS;Hsiao, CF
    貢獻者: Division of Clinical Trial Statistics
    摘要: Background: The regulatory agencies in Taiwan defines NCE2 (New Chemical Entity 2) as those compound drugs that have been approved and marketed for five years in the top ten pharmaceutically advanced countries but are new in Taiwan. To apply registration of NCE2 in Taiwan, a clinical trial may be conducted in Taiwan to evaluate the efficacy and safety. However, if the trial design is based conventional significance testing, the requirement of large sample is inevitable. Objectives: We will design a clinical trial to evaluate the efficacy and safety of NCE2 based on the concept of consistency. Methods: We propose a Bayeian approach to design and evaluation of NCE2 trial. More specifically, an empirical Bayes method with a mixture prior information is suggested to synthesize the data from both Taiwan and other countries to assess the onsistency of the treatment effect of NCE2 in Taiwan with other countries. Results: Since the NCE2 has been approved in at least one of in the top ten pharmaceutically advanced countries, we can construct the empirical prior information for the treatment effect for the NCE2 trial on the basis of all of the observed data from other countries. We will conclude similarity between the NCE2 trial and the results from other countries if the posterior probability of deriving a positive treatment effect in the NCE2 trial is large, say 80%. Numerical examples illustrate applications of the proposed approach in different scenarios. Methods for sample size determination for the NCE2 trial are also proposed. Conclusions: We have developed a Bayeian approach to design and evaluation of NCE2 trial. For assessment of the treatment effect of NCE2, the similarity criterion is established by a Bayesian approach. The concept of similarity is based on statistical prediction instead of conventional significance testing. With this approach, the total sample size required for the NCE2 trial might be reduced. That is, shortening the total duration of conducting the NCE2 trial may be possible.
    日期: 2014-10
    關聯: Pharmacoepidemiology and Drug Safety. 2014 Oct;23(S1):432.
    Link to: http://dx.doi.org/10.1002/pds.3701
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1053-8569&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000342763600798
    顯示於類別:[蕭金福] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000342763600798.pdf72KbAdobe PDF597檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋